REZUROCK is definitely an inhibitor of UGT1A1. Coadministration of REZUROCK by using a UGT1A1 substrate lowered plasma concentrations in the glucuronide metabolite, which can increase the possibility of adverse reactions connected with sensitive substrates of UGT1A1The photographs or other third party content in the following paragraphs are include